Walk Ahead for a Brain Tumor Cure on Oct. 22
The eighth annual Walk Ahead for a Brain Tumor event is expected to draw its traditional crowd of thousands on Sunday, Oct. 22.
Survivors, caregivers, family, friends, brain tumor specialists and community members participate in this inspiring walk to benefit the research and educational efforts of the University of Cincinnati Brain Tumor Center at the University of Cincinnati Gardner Neuroscience Institute.
The chip-timed 5K run begins at 8:30 a.m. at Sawyer Point Park in downtown Cincinnati. The 5K walk begins at 9 a.m. The route is wheelchair accessible. Rick June and Mike Perez are this years co-chairs.
Walk Ahead is a way to show solidarity and support for loved ones while also contributing to real progress as we gather momentum on brain tumor researchand its a lot of fun, said June, the father of a brain tumor survivor. Ive participated in many 5Ks across many disease areas, and none have the depth of spirit that I've experienced with Walk Ahead. I think its because a brain cancer diagnosis has gone from being an immediate death sentence to a field where there is renewed hope. That feeling of hope is palpable at this event.
The 2016 walk raised more than $335,000 thanks to more than 3,300 walkers, runners and supporters.
For more information visit walkahead.org or email alexandra.lolli@uc.edu
Related Stories
Join the Information Security Outreach Roadshow
December 11, 2023
The UC Office of Information Security announces the Information Security Outreach Roadshows, interactive sessions designed to enhance cybersecurity skills university-wide. Starting January 2024, the program covers key topics like password management and phishing awareness, fostering a stronger digital security community at UC.
UC grads celebrate while looking to future
December 8, 2023
UC celebrated fall commencement at Fifth Third Arena, recognizing more than 2,500 graduates.
Local 12: UC stroke study aims to give patients more treatment...
December 8, 2023
The University of Cincinnati's Pooja Khatri and Eva Mistry spoke with Local 12 about the SISTER trial that will test a new drug to treat patients with strokes who are not eligible to receive traditional treatments due to timing factors or risk of complications.